1. Macrophage-Biomimetic Nanoplatform-Based Therapy for Inflammation-Associated Diseases.
- Author
-
Qu Y, Chu B, Li J, Deng H, Niu T, and Qian Z
- Subjects
- Humans, Animals, Biomimetic Materials chemistry, Biomimetic Materials pharmacology, Biomimetics, Drug Delivery Systems, Macrophages drug effects, Macrophages immunology, Inflammation drug therapy, Nanoparticles chemistry
- Abstract
Inflammation-associated diseases are very common clinically with a high incidence; however, there is still a lack of effective treatments. Cell-biomimetic nanoplatforms have led to many breakthroughs in the field of biomedicine, significantly improving the efficiency of drug delivery and its therapeutic implications especially for inflammation-associated diseases. Macrophages are an important component of immune cells and play a critical role in the occurrence and progression of inflammation-associated diseases while simultaneously maintaining homeostasis and modulating immune responses. Therefore, macrophage-biomimetic nanoplatforms not only inherit the functions of macrophages including the inflammation tropism effect for targeted delivery of drugs and the neutralization effect of pro-inflammatory cytokines and toxins via membrane surface receptors or proteins, but also maintain the functions of the inner nanoparticles. Macrophage-biomimetic nanoplatforms are shown to have remarkable therapeutic efficacy and excellent application potential in inflammation-associated diseases. In this review, inflammation-associated diseases, the physiological functions of macrophages, and the classification and construction of macrophage-biomimetic nanoplatforms are first introduced. Next, the latest applications of different macrophage-biomimetic nanoplatforms for the treatment of inflammation-associated diseases are summarized. Finally, challenges and opportunities for future biomedical applications are discussed. It is hoped that the review will provide new ideas for the further development of macrophage-biomimetic nanoplatforms., (© 2023 Wiley‐VCH GmbH.)
- Published
- 2024
- Full Text
- View/download PDF